X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (24120) 24120
Publication (2645) 2645
Newsletter (461) 461
Book Review (72) 72
Book Chapter (54) 54
Conference Proceeding (27) 27
Dissertation (7) 7
Data Set (6) 6
Magazine Article (6) 6
Book / eBook (5) 5
Paper (2) 2
Newspaper Article (1) 1
Reference (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
animals (14509) 14509
oligopeptides - pharmacology (14201) 14201
humans (11449) 11449
index medicus (8157) 8157
male (7624) 7624
rats (5793) 5793
mice (5153) 5153
oligopeptides - chemistry (4787) 4787
female (4291) 4291
biochemistry & molecular biology (4047) 4047
amino acid sequence (3627) 3627
pharmacology & pharmacy (3488) 3488
oligopeptides - metabolism (3205) 3205
peptides (3097) 3097
molecular sequence data (2603) 2603
dose-response relationship, drug (2602) 2602
oligopeptides - therapeutic use (2537) 2537
oligopeptides - administration & dosage (2271) 2271
cells, cultured (2205) 2205
oligopeptides (1879) 1879
oligopeptides - chemical synthesis (1874) 1874
in vitro techniques (1799) 1799
cell line, tumor (1705) 1705
expression (1682) 1682
rats, sprague-dawley (1624) 1624
cell biology (1623) 1623
structure-activity relationship (1609) 1609
apoptosis (1572) 1572
kinetics (1552) 1552
cell line (1486) 1486
analysis (1482) 1482
time factors (1477) 1477
adult (1460) 1460
research (1435) 1435
apoptosis - drug effects (1427) 1427
middle aged (1403) 1403
neurosciences (1395) 1395
proteins (1343) 1343
oncology (1252) 1252
rats, wistar (1242) 1242
article (1194) 1194
cells (1165) 1165
cancer (1135) 1135
in-vitro (1123) 1123
activation (1079) 1079
oligopeptides - adverse effects (991) 991
chemistry, medicinal (990) 990
disease models, animal (981) 981
endocrinology & metabolism (970) 970
cell survival - drug effects (960) 960
peptide (957) 957
immunology (956) 956
protein binding (943) 943
mice, inbred c57bl (939) 939
cell adhesion - drug effects (933) 933
ligands (924) 924
binding (915) 915
receptor (897) 897
biophysics (883) 883
peptide fragments - pharmacology (879) 879
in-vivo (864) 864
enzyme inhibitors - pharmacology (860) 860
inhibition (848) 848
oligopeptides - pharmacokinetics (841) 841
physiology (841) 841
research article (833) 833
antineoplastic agents - pharmacology (832) 832
chemistry, multidisciplinary (832) 832
physiological aspects (819) 819
models, molecular (815) 815
cell proliferation - drug effects (805) 805
aged (804) 804
medicine, research & experimental (804) 804
binding sites (795) 795
protein (767) 767
tumor cells, cultured (751) 751
rabbits (749) 749
peptides - pharmacology (741) 741
peptides, cyclic - pharmacology (738) 738
hematology (734) 734
treatment outcome (722) 722
blood pressure - drug effects (703) 703
mice, inbred balb c (700) 700
signal transduction - drug effects (695) 695
identification (688) 688
therapy (684) 684
signal transduction (680) 680
cysteine proteinase inhibitors - pharmacology (678) 678
drug therapy, combination (672) 672
health aspects (668) 668
receptors (663) 663
rat (658) 658
guinea pigs (645) 645
piperidines - pharmacology (645) 645
phosphorylation (640) 640
multidisciplinary sciences (639) 639
molecular structure (634) 634
microbiology (631) 631
gene expression (621) 621
inflammation (621) 621
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (23706) 23706
Russian (472) 472
Chinese (130) 130
German (89) 89
Japanese (66) 66
French (53) 53
Spanish (44) 44
Italian (14) 14
Hungarian (9) 9
Polish (9) 9
Ukrainian (9) 9
Danish (4) 4
Hebrew (2) 2
Bulgarian (1) 1
Croatian (1) 1
Czech (1) 1
Dutch (1) 1
Finnish (1) 1
Slovak (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


2013, ISBN 0521190355, xiii, 393 p., [8] p. of plates
The mammalian neurohypophyseal peptide hormones oxytocin and vasopressin act to mediate human social behavior - they affect trust and social relationships and... 
Drugs | Biology, life sciences | Behavior | Drug effects | Oxytocin | Vasopressin | Behavior modification | Peptides
Book
Journal Article
The Journal of Infectious Diseases, ISSN 0022-1899, 6/2011, Volume 203, Issue 12, pp. 1791 - 1801
Background. Long-term effects of abacavir (ABC)-lamivudine (3TC), compared with tenofovir (TDF)-emtricitabine (FTC) with efavirenz (EFV) or atazanavir plus... 
HIV/AIDS | Percentage change | RNA | Spine | Bones | Bone density | Arm | Hip | Bone fractures | HIV 1 | Arts | INFECTIOUS DISEASES | EFFICACY | INITIATION | MICROBIOLOGY | PREVALENCE | IMMUNOLOGY | COMBINATION | OSTEOPOROSIS | HIV-INFECTED PATIENTS | WOMEN | THERAPY | COHORT | HEALTH | Humans | Middle Aged | Antiretroviral Therapy, Highly Active - adverse effects | Fractures, Bone - epidemiology | Male | Oligopeptides - adverse effects | Viral Load | Lamivudine - adverse effects | Tenofovir | Pyridines - adverse effects | Adenine - adverse effects | Ritonavir - adverse effects | Atazanavir Sulfate | Adult | Deoxycytidine - adverse effects | Female | Dideoxynucleosides - adverse effects | Drug Therapy, Combination | Emtricitabine | Adenine - analogs & derivatives | Osteoporosis - chemically induced | Anti-HIV Agents - adverse effects | Risk Factors | Organophosphonates - adverse effects | Benzoxazines - adverse effects | CD4 Lymphocyte Count | Absorptiometry, Photon | Bone Density - drug effects | HIV Infections - complications | Intention to Treat Analysis | HIV Infections - drug therapy | Fractures, Bone - chemically induced | Deoxycytidine - analogs & derivatives | Drug Combinations | Usage | Care and treatment | Ritonavir | Drug utilization | Lamivudine | Efavirenz | Prevention | Abacavir | Dosage and administration | Drug therapy, Combination | Drug therapy | HIV infection | Major and Brief Reports
Journal Article
American Journal of Physiology - Heart and Circulatory Physiology, ISSN 0363-6135, 02/2009, Volume 296, Issue 2, pp. 404 - 412
Galectin-3 (Gal-3) is secreted by activated macrophages. In hypertension, Gal-3 is a marker for hypertrophic hearts prone to develop heart failure. Gal-3... 
N-acetyl-seryl-aspartyl-lysyl-proline | Inflammation | Cardiac dysfunction | Fibrosis | CARDIAC & CARDIOVASCULAR SYSTEMS | PHYSIOLOGY | MYOCARDIAL-INFARCTION | HEART-FAILURE | MAST-CELLS | AC-SDKP | PRO | ANGIOTENSIN-CONVERTING ENZYME | MACROPHAGE ACTIVATION | inflammation | ANGIOGENESIS IN-VITRO | PERIPHERAL VASCULAR DISEASE | cardiac dysfunction | fibrosis | HYPERTENSIVE-RATS | Inflammation - chemically induced | Phosphorylation | Body Weight - drug effects | Myocardial Contraction - drug effects | Male | Smad3 Protein - metabolism | Heart Rate - drug effects | Inflammation - metabolism | Time Factors | Myocardium - metabolism | Echocardiography, Doppler | Anti-Inflammatory Agents - administration & dosage | Blood Pressure - drug effects | Disease Models, Animal | Macrophages - pathology | Oligopeptides - blood | Anti-Inflammatory Agents - pharmacology | Cardiac Output - drug effects | Ventricular Function, Left - drug effects | Cardiomegaly - physiopathology | Infusions, Parenteral | Rats | Stroke Volume - drug effects | Myocardium - pathology | Cardiotonic Agents - pharmacology | Mast Cells - drug effects | Rats, Sprague-Dawley | Anti-Inflammatory Agents - blood | Collagen - metabolism | Animals | Cardiomegaly - prevention & control | Cardiotonic Agents - administration & dosage | Signal Transduction - drug effects | Cardiotonic Agents - blood | Isoproterenol - pharmacology | Mast Cells - pathology | Cardiomegaly - chemically induced | Galectin 3 | Macrophages - drug effects | Hemodynamics - drug effects | Inflammation - prevention & control | Oligopeptides - administration & dosage | Oligopeptides - pharmacology | Transforming Growth Factor beta - metabolism | Ventricular Remodeling - drug effects | Cardiomegaly - metabolism | Inflammation - physiopathology | Index Medicus
Journal Article
European Urology, ISSN 0302-2838, 2017, Volume 72, Issue 1, pp. 142 - 150
Journal Article
Neuropsychopharmacology, ISSN 0893-133X, 04/2013, Volume 38, Issue 5, pp. 729 - 742
Journal Article
Psychopharmacology, ISSN 0033-3158, 10/2016, Volume 233, Issue 19-20, pp. 3647 - 3657
The N-methyl-d-aspartate (NMDA) receptor antagonists, including R-ketamine and rapastinel (formerly GLYX-13), show rapid antidepressant effects in animal... 
Antidepressant | R-ketamine | Rapastinel | Brain-derived neurotrophic factor | Synaptogenesis | PATH | FUNCTIONAL PARTIAL AGONIST | BDNF | PSYCHIATRY | D-ASPARTATE ANTAGONIST | NEUROSCIENCES | TRIAL | GLYX-13 | PHARMACOLOGY & PHARMACY | SUSTAINED ANTIDEPRESSANT | RAPID-ONSET | Nucleus Accumbens - metabolism | Disks Large Homolog 4 Protein - metabolism | Disks Large Homolog 4 Protein - drug effects | Male | Hippocampus - drug effects | Brain - metabolism | Brain-Derived Neurotrophic Factor - drug effects | Depression - drug therapy | CA3 Region, Hippocampal - drug effects | Prefrontal Cortex - drug effects | Dentate Gyrus - drug effects | Stress, Psychological - metabolism | CA3 Region, Hippocampal - metabolism | Antidepressive Agents - pharmacology | Brain-Derived Neurotrophic Factor - metabolism | Swimming | Receptor, trkB - drug effects | Receptors, AMPA - metabolism | Disease Models, Animal | Dentate Gyrus - metabolism | Excitatory Amino Acid Antagonists - pharmacology | Hindlimb Suspension | Brain - drug effects | Hippocampus - metabolism | Animals | Prefrontal Cortex - metabolism | Mice | Ketamine - pharmacology | Nucleus Accumbens - drug effects | Oligopeptides - pharmacology | Receptor, trkB - metabolism | Receptors, AMPA - drug effects | Ketamine | Antidepressants | Depression, Mental | Comparative analysis | Drug therapy | Stress (Psychology) | Health aspects | Psychopharmacology | Stress | Original Investigation
Journal Article
British Journal of Pharmacology, ISSN 0007-1188, 04/2014, Volume 171, Issue 8, pp. 2029 - 2050
A decline in energy is common in aging, and the restoration of mitochondrial bioenergetics may offer a common approach for the treatment of numerous... 
SS‐31 | reactive oxygen species | mitochondrial permeability transition | bendavia | Szeto‐Schiller peptides | cytochrome c | cytochrome c peroxidase | mitochondria cristae | oxidative stress | SS-31 | Szeto-Schiller peptides | RAT-BRAIN MITOCHONDRIA | ISCHEMIA-REPERFUSION INJURY | SKELETAL-MUSCLE | THIOL REDOX STATE | ELECTRON-PARAMAGNETIC-RESONANCE | PERMEABLE PEPTIDE ANTIOXIDANTS | TARGETED ANTIOXIDANT | HEART INTERFIBRILLAR MITOCHONDRIA | PHARMACOLOGY & PHARMACY | CYTOCHROME-C RELEASE | Cardiolipins - drug effects | Permeability - drug effects | Mitochondrial Membranes - physiology | Cytochromes c - metabolism | Humans | Aging - drug effects | Clinical Trials as Topic | Mitochondria - metabolism | Mitochondria - drug effects | Adenosine Triphosphate - biosynthesis | Lipid Peroxidation - physiology | Oligopeptides - therapeutic use | Peptides - pharmacology | Mitochondrial Membranes - drug effects | Animals | Cell Death - physiology | Lipid Peroxidation - drug effects | Oxidation-Reduction - drug effects | Mitochondria - physiology | Oligopeptides - pharmacology | Energy Metabolism - drug effects | Molecular Targeted Therapy - methods | Peptides - therapeutic use | Aging - metabolism | Membrane lipids | Mitochondrial DNA | Cardiolipin | Permeability | Health aspects | Bioenergetics | Phosphorylation | Energy, Injury & Beyond | Mitochondrial Pharmacology | Themed Issue
Journal Article
Biomaterials, ISSN 0142-9612, 2012, Volume 34, Issue 1, pp. 262 - 274
Abstract Single-walled carbon nanotubes (SWNTs) are special nano-materials which exhibit interesting physical and chemical properties, presenting new... 
Advanced Basic Science | Dentistry | Photothermal therapy | NGR | RNAi | Tumor-targeting | Single-walled carbon nanotubes | MATERIALS SCIENCE, BIOMATERIALS | EFFICIENT INTRACELLULAR DELIVERY | GENE DELIVERY | DRUG-DELIVERY | ENGINEERING, BIOMEDICAL | QUANTUM DOTS | BREAST-CANCER CELLS | IN-VIVO | CHEMISTRY | AMINOPEPTIDASE-N | SIRNA | WATER | Organ Specificity - drug effects | Endocytosis - radiation effects | RNA Interference - drug effects | Apoptosis - drug effects | Apoptosis - radiation effects | Humans | Male | RNA, Messenger - metabolism | Spectroscopy, Fourier Transform Infrared | Drug Delivery Systems | Neoplasms - therapy | Telomerase - genetics | Transfection | Lasers | Polyethyleneimine - chemistry | Hyperthermia, Induced | Telomerase - metabolism | Gene Expression Regulation, Neoplastic - drug effects | Polyethyleneimine - chemical synthesis | Cell Survival - drug effects | Endocytosis - drug effects | RNA, Messenger - genetics | Nanotubes, Carbon - ultrastructure | Combined Modality Therapy | RNA Interference - radiation effects | Cell Survival - radiation effects | Phototherapy | Organ Specificity - radiation effects | Animals | Nanotubes, Carbon - chemistry | Cell Line, Tumor | Gene Expression Regulation, Neoplastic - radiation effects | Mice | Mice, Inbred BALB C | Neoplasms - pathology | Oligopeptides - pharmacology | RNA, Small Interfering - metabolism | Cysteine | Care and treatment | Biological products | Peptides | Analysis | Nanotubes | Polymerization | Chemical properties | Tumors | Cancer | Index Medicus
Journal Article